Van Cleef Asset Management,Inc Merck & Co., Inc. Transaction History

Van Cleef Asset Management,Inc

$876 Million
Q3 2024

A detailed history of Van Cleef Asset Management,Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Van Cleef Asset Management,Inc holds 21,068 shares of MRK stock, worth $2.09 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

21,068

Previous 21,056 0.06%

Holding current value

$2.09 Million

Previous $2.61 Million 8.21%

% of portfolio

0.27%

Previous 0.34%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$111.15 - $128.97 $1,333 - $1,547	12 Added 0.06%	21,068 $2.39 Million
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $18,570 - $19,944	-150 Reduced 0.71%	21,056 $2.61 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $22,534 - $26,258	-199 Reduced 0.93%	21,206 $2.8 Million
Q4 2023 Feb 02, 2024	SELL	$100.18 - $109.02 $20,236 - $22,022	-202 Reduced 0.93%	21,405 $2.33 Million
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $15,236 - $16,920	-148 Reduced 0.68%	21,607 $2.22 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $22,265 - $24,267	205 Added 0.95%	21,755 $2.51 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $15,338 - $17,114	-149 Reduced 0.69%	21,550 $2.29 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $17,575 - $22,534	-201 Reduced 0.92%	21,699 $2.41 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $12,679 - $14,243	-150 Reduced 0.68%	21,900 $1.89 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $18,701 - $21,199	-224 Reduced 1.01%	22,050 $2.01 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $2,891 - $3,621	40 Added 0.18%	22,274 $1.71 Million
Q2 2020 Aug 17, 2020	SELL	$70.42 - $80.13 $619,696 - $705,144	-8,800 Reduced 28.36%	22,234 $1.72 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $19,008 - $26,345	-300 Reduced 0.96%	31,034 $2.39 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $14,303 - $15,590	-188 Reduced 0.6%	31,334 $2.64 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $59,143 - $67,456	850 Added 2.77%	31,522 $2.62 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $29,357 - $34,069	-450 Reduced 1.45%	30,672 $2.34 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $13,614 - $16,010	-236 Reduced 0.75%	31,122 $2.21 Million
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $50 - $59	1 Added 0.0%	31,358 $1.9 Million
Q1 2018 May 04, 2018	SELL	$50.96 - $59.23 $56,005 - $65,093	-1,099 Reduced 3.39%	31,357 $1.71 Million
Q4 2017 Feb 02, 2018	BUY	$51.62 - $61.64 $470,413 - $561,725	9,113 Added 39.04%	32,456 $1.83 Million
Q3 2017 Oct 27, 2017	BUY	$58.67 - $63.13 $1.37 Million - $1.47 Million	23,343	23,343 $1.5 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

News

Stay updated on Van Cleef Asset Management,Inc with notifications on news.

Account

Van Cleef Asset Management,Inc Merck & Co., Inc. Transaction History